Together, they provide evidence for the utility of berberine as an adjuvant therapy in addressing a range of resistance and survival pathways in breast cancer
However, following administration of the ferroptosis inhibitors liproxstatin-1 or ferrostatin-1, the levels of inflammatory factors and ROS are reduced, endogenous antioxidant pathways related to Nrf2, HO-1, and NQO1 are upregulated, transforming growth factor- expression is downregulated, and iron ptosis is reduced in lung tissue [107]
A non-GLP-1 alternative with different side effect profiles
These studies were supported by P50 GM115318 from the National Institute of General Medical Sciences (R.M.K., M.W.M., K.R.), U54 DK120342 from the National Institute of Diabetes and Digestive and Kidney Disease/Office of Research on Womens Health (K.R.), U54 HL170326 from the National Heart Lung and Blood Institute/Office of Research on Womens Health, R21 AR077782 (K.R
Second, administration route matters: Matrixyl is limited to topical application, while GHK-Cus water solubility and established injectable safety data expand the research design space considerably